0001022079-21-000117.txt : 20210730 0001022079-21-000117.hdr.sgml : 20210730 20210730161608 ACCESSION NUMBER: 0001022079-21-000117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210728 FILED AS OF DATE: 20210730 DATE AS OF CHANGE: 20210730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUSCKOWSKI STEPHEN H CENTRAL INDEX KEY: 0001142624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 211132754 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_162767612798957.xml FORM 4 X0306 4 2021-07-28 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001142624 RUSCKOWSKI STEPHEN H 500 PLAZA DRIVE SECAUCUS NJ 07094 1 1 0 0 Chairman, CEO and President Common Stock 2021-07-28 4 M 0 139751 95.795 A 424178 D Common Stock 2021-07-28 4 S 0 139751 140.141 D 284427 D Common Stock 2021-07-29 4 M 0 5300 95.795 A 289727 D Common Stock 2021-07-29 4 S 0 5300 140.591 D 284427 D Common Stock 2021-07-29 4 M 0 4193 95.795 A 288620 D Common Stock 2021-07-29 4 S 0 4193 141.216 D 284427 D Non-Qualifed Stock Option (right to buy) 95.795 2021-07-28 4 M 0 139751 95.795 D 2027-02-21 Common Stock 139751.0 9493 D Non-Qualifed Stock Option (right to buy) 95.795 2021-07-29 4 M 0 5300 95.795 D 2027-02-21 Common Stock 5300.0 4193 D Non-Qualifed Stock Option (right to buy) 95.795 2021-07-29 4 M 0 4193 95.795 D 2027-02-21 Common Stock 4193.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski 2021-07-30